Kevin Whaley

Kevin Whaley has worked for the last 30 years on the development of MPTs to prevent sexually transmitted diseases and unintended pregnancy. He co-founded Mapp Biopharmaceutical to develop antibody-based MPTs, therapeutics and mucosal vaccines that are appropriate for large, cost-sensitive, global health markets.


Spread the word about the promise of MPTs.


We will go further together – join the movement for MPTs.


Your financial and in-kind support can help make MPTs a reality.